论文部分内容阅读
目的:探讨介入治疗重症急性胰腺炎(SAP)的临床应用价值。方法:回顾分析2009-03-2014-02我院收治的42例SAP的病历资料,全部病例均行EST或B超、CT引导下经皮穿刺,置管引流胰周积液及局部并发症。结果:42例患者中7例经EST+ENBD治愈,29例经皮置管引流后成功治愈,6例引流失败,行外科手术治疗,死亡5例,总治愈率88.1%,病死率11.9%,无导管相关性并发症。结论:对于SAP采用EST或经皮置管引流是一种安全有效的治疗方法,对于选择适当的病例,可以避免传统外科手术。
Objective: To investigate the clinical value of interventional treatment of severe acute pancreatitis (SAP). Methods: The data of 42 cases of SAP treated in our hospital from March 2009 to February 2014 were retrospectively analyzed. All cases underwent EST or B ultrasound. CT guided percutaneous puncture, catheter drainage and pancreatic peripancreatic fluid and local complications were performed. Results: Among the 42 patients, 7 cases were cured by EST + ENBD, 29 cases were successfully treated by percutaneous catheter drainage, 6 cases failed drainage. Surgical treatment resulted in 5 deaths. The total cure rate was 88.1% and the case fatality rate was 11.9% No catheter-related complications. Conclusions: The use of EST or percutaneous catheter drainage for SAP is a safe and effective method of treatment, which avoids the need for traditional surgical procedures in the selection of appropriate cases.